Status:

RECRUITING

PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study

Lead Sponsor:

University Hospital, Ghent

Collaborating Sponsors:

Organon

Conditions:

Ovarian Stimulation

Quality of Life

Eligibility:

FEMALE

18-40 years

Phase:

PHASE4

Brief Summary

P-CCROSS is a randomized, prospective monocentric phase 4 study with a crossover study design. The aim of the study is to compare patient satisfaction (by means of questionnaires) and treatment compli...

Eligibility Criteria

Inclusion

  • Prescreening: Clarification: Pre-screening might be performed to identify women with AFC \> 5 and AMH \> 1.1 ng/ml (Bologna criteria, AFC and AMH values are valid for one year).
  • Inclusion criteria for:
  • Group 1: indication for oocyte cryopreservation
  • Group 2: indication for IVF/ICSI and PGT-A
  • Inclusion criteria for both groups:
  • First ovarian stimulation cycle
  • Aged ≥ 18 and \< 41 years old at the time of first OPU
  • Exclusion Criteria:
  • contra-indication for ovarian stimulation
  • expected poor ovarian response (Bologna Criteria)
  • PCOS patients
  • refusal to fill out questionnaires before, during and after treatment
  • simultaneous participation in another clinical study
  • untreated and uncontrolled thyroid dysfunction;
  • current use of oral contraceptives, anti-psychotics, anti-epileptics or chemotherapy;
  • pregnant or breastfeeding women. A woman is considered of childbearing potential (WOCBP), i.e. fertile, following menarche and until becoming postmenopausal unless permanently sterile. Permanent sterilization methods include hysterectomy, bilateral salpingectomy and bilateral oophorectomy. A postmenopausal state is defined as no menses for 12 months without an alternative medical cause.

Exclusion

    Key Trial Info

    Start Date :

    January 27 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2027

    Estimated Enrollment :

    60 Patients enrolled

    Trial Details

    Trial ID

    NCT06175832

    Start Date

    January 27 2025

    End Date

    December 31 2027

    Last Update

    December 26 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University Hospital Ghent

    Ghent, Belgium, 9000